These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 22204482
1. From the pharmacophore to the homology model of the benzodiazepine receptor: the indolyglyoxylamides affair. Cosimelli B, Cosconati S, Marinelli L, Novellino E, Greco G. Curr Top Med Chem; 2012; 12(4):321-32. PubMed ID: 22204482 [Abstract] [Full Text] [Related]
2. Geometrically constrained derivatives of indolylglyoxylamides as ligands binding the GABAA/BzR complex. Sartini S, Morelli M, Simorini F, Taliani S, Salerno S, Marini AM, Da Settimo F, La Motta C. Curr Top Med Chem; 2012; 12(4):312-20. PubMed ID: 22204489 [Abstract] [Full Text] [Related]
3. Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents. Salerno S, Da Settimo F, Taliani S, Simorini F, La Motta C, Fornaciari G, Marini AM. Curr Top Med Chem; 2012; 12(4):286-311. PubMed ID: 22204484 [Abstract] [Full Text] [Related]
4. Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effects. Simorini F, Marini AM, Taliani S, La Motta C, Salerno S, Pugliesi I, Da Settimo F. Curr Top Med Chem; 2012; 12(4):333-51. PubMed ID: 22204487 [Abstract] [Full Text] [Related]
5. Novel N-(arylalkyl)indol-3-ylglyoxylylamides targeted as ligands of the benzodiazepine receptor: synthesis, biological evaluation, and molecular modeling analysis of the structure-activity relationships. Primofiore G, Settimo FD, Taliani S, Marini AM, Novellino E, Greco G, Lavecchia A, Besnard F, Trincavelli L, Costa B, Martini C. J Med Chem; 2001 Jul 05; 44(14):2286-97. PubMed ID: 11428922 [Abstract] [Full Text] [Related]
7. Novel N-substituted indol-3-ylglyoxylamides probing the LDi and L1/L2 lipophilic regions of the benzodiazepine receptor site in search for subtype-selective ligands. Primofiore G, Taliani S, Da Settimo F, Marini AM, La Motta C, Simorini F, Patrizi MP, Sergianni V, Novellino E, Greco G, Cosimelli B, Calderone V, Montali M, Besnard F, Martini C. J Med Chem; 2007 Apr 05; 50(7):1627-34. PubMed ID: 17335185 [Abstract] [Full Text] [Related]
8. N'-Phenylindol-3-ylglyoxylohydrazide derivatives: synthesis, structure-activity relationships, molecular modeling studies, and pharmacological action on brain benzodiazepine receptors. Da Settimo A, Primofiore G, Da Settimo F, Marini AM, Novellino E, Greco G, Gesi M, Martini C, Giannaccini G, Lucacchini A. J Med Chem; 1998 Sep 24; 41(20):3821-30. PubMed ID: 9748357 [Abstract] [Full Text] [Related]
9. The GABAA-BZR complex as target for the development of anxiolytic drugs. Trincavelli ML, Da Pozzo E, Daniele S, Martini C. Curr Top Med Chem; 2012 Sep 24; 12(4):254-69. PubMed ID: 22204488 [Abstract] [Full Text] [Related]
19. Identification of anxiolytic/nonsedative agents among indol-3-ylglyoxylamides acting as functionally selective agonists at the gamma-aminobutyric acid-A (GABAA) alpha2 benzodiazepine receptor. Taliani S, Cosimelli B, Da Settimo F, Marini AM, La Motta C, Simorini F, Salerno S, Novellino E, Greco G, Cosconati S, Marinelli L, Salvetti F, L'Abbate G, Trasciatti S, Montali M, Costa B, Martini C. J Med Chem; 2009 Jun 25; 52(12):3723-34. PubMed ID: 19469479 [Abstract] [Full Text] [Related]